Approval · Notice of Compliance 883 · 2001
ASAPHEN: Notice of Compliance 883
Issued August 3, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 883
- Date
- August 3, 2001
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Analgesic, anti-inflammatory, antipyretic, platelet aggregation inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ASAPHEN | 02243974 | Marketed |
Medicinal ingredients
- ACETYLSALICYLIC ACID 81 MG per TAB